Analysis of Carbohydrate Properties Essential for Melanogenesis in Tyrosinases of Cultured Malignant Melanoma Cells by Differential Carbohydrate Processing Inhibition  by Imokawa, Genji
Analysis of Carbohydrate Properties Essential for 
Melanogenesis in Tyrosinases of Cultured Malignant 
Melanoma Cells by Differential Carbohydrate 
Processing Inhibition 
Genji Imokawa, M.S., Ph.D. 
Toch1g1 Research Laboratones, Kao Corporation, Tochigi, Japan 
In order to clarify the biologic significance of carbohydrate 
processing in tyrosinases for melanogenesis, we have studied 
the effect of differential carbohydrate processing inhibitors 
on the recovery process of interrupted melanization which 
occurs after exposure of cultured B-16 melanoma cells to the 
inhibitor of core carbohydrate synthesis, glucosamine (Glc). 
Treatment of this glycosylation-dependent repigmentation 
process with the early-stage carbohydrate processing inhibi-
tors deoxynojirimycin (dNM), castanospermine (CS), and 
monensin (MS) at 0.8 mM, 40 .ug/ml, and 30 nM, respec-
tively, in the presence of 2 mM theophylline (Tp) almost 
completely inhibits the reappearance of the pigment 48-
72 h after removal of Glc. In contrast, treatment with the 
later stage carbohydrate processing inhibitor swaisonine 
(SW) at 40-80 pgjml does not interrupt the repigmentation 
process. Electrophoretic analysis of tyrosinases in the soluble 
fractions of these melanoma cells demonstrates that the alter-
ation of soluble tyrosinase isozymes by all the processing 
inhibitors is associated with a dose-dependent loss of sialic 
W e previously demonstrated [1,2] that melano-genesis is regulated by intracellular matura-tion and translocation of the melanin-synthesizing enzyme, tyrosinase and by differentiation of the tyrosinase-accepting or-
ganelles, premelanosomes, which are the specific site where mela-
nin polymer is formed. Specific inhibirion of core carbohydrate 
synthesis by runicamycin (TM} and Glc results in a marked loss of 
melano~enesis with no substantial change in total tyrosinase acriv-
ity [3,4], and is accompanied by alterarion of the carbohydrate 
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Abbreviations: 
AHP: ammohydroxyphenylalanin 
Con A: concanavalin A 
CS: castanospermme 
DOC: deoxycholate 
Dopa: d1hydroxyphcnylalamn 
dNM: deoxynojirimycin 
GERL: Golgi-assoctatcd endoplasmic reticulum of lysosome 
Glc: glucosamine hydrochlondc 
acid-rich T 1 tyrosinase and the concomitant appearance or 
increase of sialic acid-poor tyrosinases. In the large granule 
fraction, a recovery of membrane-bound tyrosinase (T3) is 
seen following both MS and SW treatments, whereas dNM 
treatment results in the substantial loss ofT 3 tyrosinase. At 
the electron microscopic level, a translocation of tyrosinase 
from GERL and coated vesicles to many unrnelanized vacuo-
lar premelanosomes occurs in MS-treated cells in contrast to 
its predominant distribution in the GERL-coated 
vesicle system of dNM-treated cells, which contain many 
unmelanized premelanosomes. The present evidence for dif-
ferential effects on intracellular tyrosinase transfer and me-
lanization by different stages of carbohydrate processing in-
hibition suggests that asparagine-linked oligosaccharides, 
relating to the first mannose-trimming stages, determine the 
function of tyrosinase transfer as well as melanization 
through a specific intracellular recognition process in pig-
ment cells. J Invest Dermatol 95:39 - 49, 1990 
moiety in tyrosinases, including isozyme changes (5]. This melano-
genic inhibition is characterized by deficient intracellular transport 
of tyrosinases among subq:llular compartments with their restricted 
localization in the Golgi-associated endoplasmic reticulum of lyso-
some (GERL) and coated vesicles [6]. Thus, it has been proposed [3] 
that N-glycosidically linked oligosaccharides in tyrosinases play an 
integral role in determining their melanogenic properties, one of 
which is primarily associated with intracellular translocarion. How-
ever, little is known about what strucrural subunits of carbohydrate 
chains in tyrosinases perform a key function as signals for the tyro-
ClcNAc: N-acecylglucosamine 
GTA: glutaraldehyde 
LGF: large granule &action 
MEM: Eagle's minimal essential medium 
MS: moncnsin 
PAGE: polyacrylamide gel electrophoresis 
PB: phosphate buffer 
PMSF: phenylmethyl sulfonyl fluoride 
PTCA: pyrrolc-2,3,5-tncarboxyhc acid 
SDS: sodium dodecyl sulfate 
SW: swaisonine 
Tp: theophylline 
TM: tunicamycin 
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sinase transfer and the subsequent initiation of melanosomal melan-
ization. 
The major pathway for the biosynthesis of theN-linked oligosac-
charide chains in eucaryocytes has been shown to involve the syn-
thesis of the core tetradecasaccharides on a lipid carrier, the transfer 
of the oligosaccharide to protein from dolichol pyrophosphate and 
the subsequent processing to yield various oligosaccharide struc-
tures with the same inner core [7 - 9]. This processing includes 
removal of glucose and several mannose residues, and the addition 
of terminal sugars such as N-acetylglucosamine, galactose, fucose, 
and sialic acid that are characteristic of complex oligosaccharides. 
Thus, we have utilized four processing inhibitors, which are known 
to act at different processing stages, to clarify the role of complex 
and elaborative carbohydrate processing in pigment cell function. 
One difficulty in evaluating the effect of carbohydrate processing 
inhibitors on various stages of melanogenesis in melanoma cells is 
that there are many stages in melanization, the subcellular localiza-
tion of tyrosinases, and there are a variety of isozymes. We have 
previously found [10,11] that the recovery process of interrupted 
melanization, which occurs after exposure of cultured B-16 mela-
noma cells to Glc, synchronizes initial steps of melanogenesis which 
involve the concentration and activation of tyrosinases within a 
G ERL-coated vesicle system, its transfer to premelanosomes, and 
the initiation of melanization. Thus, we have evaluated the effect of 
carbohydrate processing inhibitors on melanogenesis in this system. 
In the present paper, we report che functional significance of trim-
ming glucose and/or high mannose subunits from carbohydrate 
chains of tyrosinases on melanogenesis within melanoma cells. 
MATERIALS AND METHODS 
Materials MethyPH-dThd (2 Ci/mmol), D-(2-3 H(N))-man-
nose {10-20 Cijmmol), 1-3,5-3H-tyrosine (40-60 Ci/mmol), and 
L-4,5,M-3H-leucine (5 Ci/mmol) were purchased from New En-
gland Nuclear (Boston, MA). TM, MS, Glc, Dopa, cycloheximide, 
agarose-bound neuraminidase, and all other materials were obtained 
from Sigma Chemical Co. (Saint Louis, MO). CS and SW were 
purchased from Calbiochem Behring. 1-dNM was obtained from 
Meiji Seika Corp. through Professor N. Otake of the Department of 
Agriculture, University of Tokyo, Tokyo, Japan. 
Cells B-16 mouse melanotic melanoma cells were cultured in 
Eagle's minimal essential medium (MEM) (Gibco) supplemented 
with 10% fetal calf serum (Gibco), 4 mM glutamine, 100 units/ml 
perticillin, and 100 J.lg/ml streptomycin, ac 37•c with 5% 
C02/95o/o air atmosphere. Glc added at the concentration of 1 
mg/ml (86.5% inhibition oPH-mannose uptake (3] co the culture 
medium was used immediately after cell seeding. Thereafter all 
medium was replaced with inhibitor-containing fresh medium 
twice a week during the cell-growth period for the present experi-
ments. In order co obtain the higher specificity for processing inhib-
itors and to show their effect promptly and clearly, experiments 
were carried out using the synchronized recovery process from the 
inhibition of core carbohydrate synthesis induced in cultured B-16 
melanoma cells by Glc. Removal of glycosylarion inhibition was 
carried out after exposure of these cells to the inhibitor for about 10 
culture days, inducing rhe complete loss of their melanization. The 
unmelanized melanoma cells were washed 3 times with Hank's 
buffer and reculcured with fresh medium free of glycosylation in-
hibitors for subsequent biochemical exami1utions. In the present 
experimental procedures, 2 mM Tp was given at the beginning of 
the recovery in order to facilitate the recovery of melanization. 
Processing inhibitors were added at che indicated concentrations 
immediately following removal of Glc. The preventive effect on 
the recovery process from interrupted melanogenesis could be 
clearly visualized after the cells were pelleted on the second or third 
day of the recovery (1 OJ. The pelleted cells were used for subsequent 
biologic experiments. 
Incorporation Experiments In order to examine the effect of 
processing inhibitors on che synthesis of carbohydrate, DNA, and 
protein through the Tp-scimulared repigmenting process (recovery 
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process of carbohydrate synthesis), cells unpigmented following 
treatment with Glc were cultured in Falcon plastic dishes (35-mm 
diameter) containing three 15 mm-diameter glass coverslips per 
dish; 3 H-mannose (2 J.1Ci/ml), 3H-dThd (1 J.1Ci/ml), and 3H-leu-
cme (l J.lCi/ml) were added to the cultures for the last I or 5 h of24 
or 48-h incubation with processing inhibitors added immediately 
after removal of Glc. After incubation, the cells were washed 3 
times with cold Hank's balanced solutiOn, and So/o cold TCA was 
added twice every 1 0 min, followed by successive treatments with 
70%, 90%, and 100% ethanol to dry the cells. The cells were dis-
solved in 0.5 ml of Soluene after incubation ac 6o•c for 24 h and 
mixed with 10 ml of toluene-based scintillation fluid. The radioac-
tivity was counted in a liquid scintillation spectrometer. 
Fractionation Subcellular fractionation was performed by the 
method of Seiji [ 12] using the cell homogenate from about 40 Fal-
con culture dishes (75 cm2). The cell pellets collected after trypsini-
zation were homogenized in an equal volume of icc-cold 0.25 M 
sucrose solution containing I mM phenylmethyl sulfonyl fluoride 
(PMSF) using a Teflon homogenizer chilled with ice. The suspen-
sion obtained was first centrifuged at 700 X g for 10 min to remove 
unn1ptured cells and nuclear debris. The residue was discarded. The 
supernatant wa.s further centrifuged at 12,000 X g for 10 min to 
obtain a soluble fraction and the LGF as a sediment. The soluble 
fraction was further centrifuged at 105,000 X g for 10 min to ob-
tain the supernatant and the small granule fraction as a sediment. 
Polyacrylamide Gel Electrophoresis Acrylamide gel electro-
phoresis was carried out according to the method of Davis [13]. One 
hundred pl of the I 05,000 X g supernatant (approximately 520 J.lg 
protein) was applied to a 7.5% acrylamide gel column without 
sodium dodecyl sulfate (SDS). Electrophoresis was carried out at pH 
8.7 in Tris-glycine buffer at 3 rnA/gel. The LGF from the cell 
homogenate wa~ suspended in 0.5% sodium deoxycholate (DOC) 
containing l mM PMSF for 20 min at 4•c and centrifuged at 
105,000 X g for 60 min. The DOC-solubilized LGF was mixed 
with an equal volume of buffer A (0.123 M Tris-HC1 pH 6.8, 20% 
glycerol, 4% SDS, 0.004% bromphenol blue) and 100 11l (approxi-
mately 210 J.lg protein) was applied to the gel. The SDS gel electro-
phoresis was carried out at pH 8. 7 in Tris-glycine buffer containing 
1o/o SDS at 1 mA/gcl according to the method of Davis [13]. After 
electrophoresis, the gel was washed with 0.3 M phosphate buffer 
(PB) and then incubated in 0.1 M PB (pH 6.8) containing 0.1 o/o 
dihydroxyphenylalanine (Dopa) ac 37•c for 5 h. The prestained 
molecular weight markers used were ovalbumin (molecular weight 
42,699), bovine serum albumin (66,200), phosphorylase b (97 ,400), 
P-galactosidase {116,250), and Myosin (200,000). Protein was visu-
alized in SDS-PAGE using Coomassie R-250 staining. 
Electron Microscopy Cultured cells were washed twice with 
Hank's balanced solution and fixed in situ with 2.5% glutaralde-
hyde (GTA) in Hanks's buffer for 60 min at 4 ·c. After being 
washed twice with the buffer in 10 min, che cells were poscfixed 
with 1 o/o uranyl acetate for 60 min and then with 1 o/o osmium 
tetroxide for 30 min. The cells were dehydrated with graded eth-
anol and embedded in Epon 812. For the electron microscopic dopa 
reaction [4]. cultured cells were fixed with 2.5% glutaraldehyde in 
Hanks' buffer for 30 min, washed twice with the same buffer for I 0 
min, and incubated in 0.1% dopa solution in 0.1 M phosphate 
buffer, pH 6.8, for 5 h at 37•c and postfixed in the manner de-
scribed above. Thin sections were cut with a Porter-Blum MT-1 
ultratome, stained with lead citrate, and examined under a JOEL 
100 ex microscope. 
Affinity Chromatography In order to concentrate the sample, 
the DOC-solubilized LGF was applied to a column (10 X 1.5 em) 
of Con A lectin-Sepharose which had been equilibrated with O.So/o 
DOC containing Tris-HCl buffer (0.01 M, pH 6.8) according to 
the method of Clemetson et al ( 14]. The column was washed with 
the same buffer until the flow-through peak had eluted and the 
absorbance of the eluent at 280 nm had returned to the base line. 
The eluent was then changed to 0.2 M alpha-methylmannoside in 
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0.5% DOC contammg buffer. The flow-through and the eluted 
fraction were separately pooled. The eluted fraction was subjected 
to Amicon filrrauon to eliminate materials with less rhan 10,000 
molecular weight. 
Neuraminidase T reatm ent Samples were treated with 5 units 
of agarose-bound neuraminidase at 37"C in 0.1 M PB (pH 6.8) for 
2 h. Treated samples were centrifuged at 2,000 rpm to obtain the 
supernatant for electrophoretic analysis. 
Statistics The level of significance of the difference was calcu-
lated by the Student t test. 
RESULTS 
Gross and Light M icroscopic Observation In order to con-
firm the reliability of the experimental system, inhibitors of core 
carbohydrate synthesis, Glc or TM, were used at the known depig-
mentary concentratiOns to the Tp-stimulated synchronized repig-
T0 12m\1 0.025 % ().05 % 0 . I % 
Tpl 2mv1 O.OS.ug,tnl O. lug ml 0.2ug ml 
c 
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menta non process. Both inhibitors have been found to clearly block 
the process at the concentrations used, respectively (Fig 1A,B). 
Treatment of remclanizing cells with early stage processing inhibi-
tor, dNM, or CS also completely inhib1rs the reappearance of the 
p1gment in the presence of2 rnM Tp without cytotoxic effect for up 
to 3d after removal of glycosylation inhibition (Fig 1 C,D). Treat-
ment of remelanizing cells with the late early stage processing in-
hibitor MS at 30-50 nM also completely inhibits the reappearance 
of the pigment in rhe presence of 2 rnM Tp {Fig lE), whereas 
treatment with the later-stage processing inhibitor SW does not 
interrupt the repigmentarion even at high concentrations (Fig IF). 
Incorporation Studies The effect of processing inhibitors on 
the recovery process of melanization has also been studied by incor-
poration of tritiated mannose by unpigmented B-16 cells after re-
moval of Glc.lt can be seen that though at 24 h after removal of Glc 
E 
Recovery 0 day 
)( 
1t~ 
rso. 
GJucosamine t reated ~to 
unpigmented ce lls 
Figure l. EIT~cl of glyco~ylation mhibitors or pr~sing inhibnors on remclam7.~tlon stimulated by Tp during rhe recovery period. B-16 cells were cultured 
wirh Glc (I rng/ ml) for a hour I 0 d, inducing complete loss of pigment. After replacement with fresh medium without Glc bur comaining 2 mM Tp, the cells 
were reculrured for an addirional3 din the presence ofGic, TM, dNM, CS, MS, or SW. A, recovery in rhe presence ofGic. B, recovery in rhe presenceofTM. 
C, recovery in the presence of dNM. D, recovery in the presence of CS. E, recovery 111 the presence of MS. F, recovery in the presence of SW. 
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Table I. Effect of Processing Inhibitors on Synthesis of 
Carbohydme, Protein and DNA During 24-h Recovery Process 
of Pigmentation Seen After Removal of Glucosamine 
3H-uucine 
3H-Mannose" (dpm/105 cell) 3H-dThd 
Theophylline 374±37 762±66 6722±235• 
(2mM) 
DeoxynoJiri-
mycm 
0.8mM 256± 16' 538±60< 8273±3341 
(3 1.6%) (29.4%) (-23.1%)' 
1.6 mM 236 ± I I' 556±20< 8236±803 
(36.9%) (27.0%) (-22.5%) 
Ca~tano~per-
rnm 
40pg/ ml 290±171 824±60 5111 ±3051 
(22.5%) (-8.1%) (24.0%) 
60pg/ml 318 ±23 7 11 ±75 4481 ±235' 
(15.0%) (6.7%) (33.3%) 
Moncmin 
3X I0- 8M 394±37 824±82 7132±233 
(-5.3%) (-8.1%) (-6.1%) 
5X 10 8M 406±60 810±47 6623±202 
(-8.6%) (-6.3%) (1.5%) 
Swamsonin 
40pg/ ml 357±29 940±97' 9671 ±614' 
(4.5%) (-23.4%) (-43.9%) 
80pg/ml 388±26 933±55' 9733±439' 
(-3.7%) (-22.4%) (-44.8%) 
• lncubauon hour wtth ach rodtoocuvc prrcusor wu thc I an 5 h of 24-h prnod for 
m•nno«' and thc last I h for thc othrrs. 
I Mc•n±SE from 6 exprnmcnu 
' p < 0.0 I over T p control. 
'p< O.OS. 
'% mlubonon. 
there is a slight inhibition of recovering core carbohydnte synthesis 
by the addition of dNM and CS at concentrations used, as compared 
to Tp control (Table I) , the carbohydnte synthesis rerurns to over 
the Tp control level unril 48 h after the remov:al (Table 11). Because 
experiments using Glc and TM demonstrated that a complete inter-
ruption of pigmentation required at least 70% inhibition of man-
nose incorporation (3], we can exclude the possibility th:at dN M also 
inhibits the core carbohydrate synthesis which results in the ob-
served mterruprion of the repigmentation process. The addition of 
MS or SW into unpigmented B-16 cells does nor significantly in-
hibit recovery of the core carbohydnte synthesis, as revealed by 
mannose uptake similar to that ofTp control. Protein synthesis as 
revealed by leucine is shghdy inhibited at 24 h by dNM and SW, 
but not significantly by the other processing inhibitors used here 
(Table I). At 48 h, they are rather stimulated by all the processing 
inhibitors except SW (Table II). Our previous srudy using cyclo-
heximide [5 J revealed that up to 45o/o inhibition of protein synthesis 
exhibits no recognizable effect on melanogenesis. DNA synthesis as 
revealed by thymidine uptake is moderately inhibited at 24 h by CS, 
but modentely stimulated by SW and dNM (Table I). At 48 h, they 
arc markedly stimulated by MS and SW (Table II). 
E lect rophoresis In the same recovery system, we have studied 
recovery dynamics of tyrosinase isozymes in soluble fraction by 
PAGE without SDS or in the LGF by SDS-PAGE after DOC solu-
bilization. On PAGE without SDS of soluble fraction from Glc-
treared cells (Fig 2), dNM causes a dose-dependent disappearance of 
T 1 tyrosinase band and a concomitant appearance of a new tyrosin-
ase band with much lower electrofhoretic mobility than T 2 tyrosin-
ase, mdicating the conversion o sialic acid-rich T 1 tyrosinase to 
sialic acid-poor or -deficient {T2) tyrosinases (Fig 2A). CS treatment 
also induces a disappearance of sialic acid-rich T 1 tyrosinase, leaving 
T 2 and sialic acid-deficient tyrosinases (Fig 2B). Similar to the dNM 
orCS effect, treatment with MS causes a dose-dependent disappear-
ance ofT1 and an increase ofT2 tyrosinases on day 2 or 3 (Fig 2C). 
SW treatment is accompanied by a disappearance ofT, together 
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w1rh a marked increase and broadening of the T 2 tyrosinase band 
which can be ever further reduced in mobility after neuraminidase 
treatment, indicating that sialic acid moieties remain in tyrosinases 
of SW-treated cells {Fig 2D). SDS-PAGE (Fig 3) shows the reap-
peannce ofT3 tyrosinase after 3-d recovery in the presence ofTp. 
The addition of MS does nor interrupt-rather, it increases-the 
recovery ofT3 tyrosinase despite the lack of melanization recovery 
compared to the Tp-rreated control, bur there 1s a decrease in the 
activity after 3-day recovery at 50 nM (Fig 3A). SW treatment is 
also accompanied by the recovery ofT 3 tyrosinase and by no sub-
stantial change in T 1 tyrosinase, although the band ofT3 tyrosinase 
becomes broad (Fig 3B). On the other hand, dNM treatment causes 
a dose-dependent decrease in T 1 and a simultaneous appearance of a 
new tyrosinase with an even lower mobility than T 3 (observed espe-
cially at 1.6 mM) {Fig 3C). Thus, the T 3 tyrosinase band is lacking 
on day 2 at 0.4 mM dNM, bur appears at 0.8 mM dNM and be-
comes a tyrosinase band with an even lower mobility than T 3 at 
1.6 mM dNM. Thus, it seems likely that the depletion of sialic acid 
also has a marked influence on elecrrophoretic mobility with SDS-
PAGE. In an attempt to examine the effect of the removal of sialic 
acid moieties on the SDS-PAGE pattern, we studied the effect of 
neurammidase treatment of tyrosinase obtained from Con-A lectin 
affinity chromatography of LGF from Tp-treated control cells (Fig 
3D) or those from dNM- {Fig 3E) or SW -treated cells {Fig 3B}. 
N eurammidase trearrnenr is accompanied by a disappearance ofT1 
as well as a concomitant appeannce of a broad band corresponding 
to T 3 tyrosinase {Fig 3D) or of a band with lower electrophoretic 
mobihty, whose characteristics are very similar to those observed by 
1-dNM treatment (Fig 3E). This demonstrates the possibility that 
an apparent decrease in electrophoretic mobility, which often looks 
like the reformation of T 3 tyrosinase, is mainly due to the lower 
mobility of sialic acid-deficient tyrosinase on SDS-PAGE. This is 
also in agreement with the fact that among processing inhibitors 
tested, only dNM can induce the appearance of a tyrosinase band 
with lower electrophoretic mobility than sialic acid-poor T 2 tyro-
sinase on PAGE. T yrosinase bands of dNM- or SW-treated cells on 
Table 11. Effect of Processing Inhibitors on Synthesis of 
C arbohydnte, Protein, and DNA During 48-h Recovery Process 
of Pigmentation Seen After Removal of Glucosamine 
3H-uueme 
3H-Mannosc' (dpm/ 10' cell) 3H-dThd 
Theophylline 1020±72 2338±309 2364±379• 
(2mM) 
DcoxynOJifl· 
my em 
0.8 mM 1464±93' 3788±392' 3242±224 
(- 43%) (-62%) (-37%)1 
1.6mM 1829± 192' 3663±474 3273±587 
(- 79%) (-56%) (- 38%) 
Cast:mosper-
man 
40pg/ ml 1983± I 16' 6698±691' 3172±484 
(-94%) (- 186%) (-34%) 
60 pg/ ml 1772± 168' 5634± 484' 3654±348 
(-73%) (- 141 %) (-55%) 
Mon~nsm 
3X 10 8M 1544 ±241 7036±1028' 3929±882 
(-51%) (-201%) (- 66%) 
5X 10 8M 2268±208' 4684±874 5270±947' 
(- 122%) (- 100%) (- 123%) 
Swamsonm 
40pg/ ml 3040 ±340< 2229± 169 14273±2045' 
(- 198%) (-4.7%) (-504%) 
80pg/ ml 3450± II I' 2436±310 26565 ± 2550< 
(-245%) (- 4.0%) (-1023%) 
• lncub•non hour wtth cach rodtoocnve precusor wos thclast 5 h of 48-h prnod for 
m~nnosc and the l•st I h for the others. 
I M•an ± SE. 
' p < O.OS. 
J % mhtl)l(oon. 
'p < O.OI over Tp control. 
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Figure 2. PAGE wathout SDS of tyrosinase present in 105,000 X g supernatant fraction from processing inhibitor-treated cells on the second or third day of 
recovery. Tyrosin:1sc acuviry is made visible with the dopa reaction. A, dNM. B, CS on day 3. C, MS. D, SW (40 J.lg/ rnl) on day 3; Neu (+):neuraminidase 
trcatmcm. 
SDS-PAG£ can also be reduced in mobility after neuraminidase 
treatment (Fig 3B,E), indicating that sialic acid moieties remain in 
tyrosinase from LGF of dNM- or SW -treated cells at concentrations 
used here. 
E lectron Microscopy Figure 4A shows the appearance of mel-
anosomes by day 3 following recovery from Glc-induced depig-
mentation in the presence ofTp. Melanization within melanosomes 
proceeds to the advanced stages having spherical, multigranular 
shapes, corresponding to pheomelanotic melanosomes. Dopa-
reacted cells on day 2 after removal of glucosamine show marked 
reaction products 10 all melanogenic compartments including 
GERL, coated vesicles as well as melanosomes (Fig 4B). MS treat-
ment during recovery is accompanied by a loss of premelanosomes 
with melanin deposition as well as a disappearance of an active 
Golgi region (Fig SA). Many of these vacuoles have a visible content 
of vesicles and filamentous materials whose structural characteris-
tics correspond to those of immature premelanosomes. Dopa-
reacted cells (Fig SB) show predominant localization of dopa mela-
nin in some areas of the inner aspect of limiting membranes of the 
immature premelanosomes and in coated vesicles. Typical GERL 
structures, characterized by markedly developed tubules and anasto-
mosing tubules with strong dopa melanin, are lacking in MS-treated 
cells. 
dNM-treated cells on day 3 of recovery show a large number of 
premelanosomes with partial re-formation of periodicity, but mela-
nin deposition was rarely seen in premelanosomes (Fig 6A). Dopa-
reacted cells (Fig 6B) on day 2 of recovery in the presence of dNM 
show a predominant localization of reaction products in well-devel-
oped GERL and coated vesicles. In contrast, premelanosomes show 
a rather weakly dopa-positive reaction, indicating that tyrosinase 
transfer is interrupted. 
DISCUSSION 
Our present processing inhibition experiments have revealed that 
impaired carbohydrate processing in the presence of dNM, CS, or 
MS results in the interruption of the remelanizing process, which 
has been shown [ 10, 11] to be primarily dependent upon the recov-
ery of synthesis of N-glycosidically-linked oligosaccharide. SW 
treatment docs not interrupt this repigmentation process. Because 
dNM, CS, and MS do not significantly inhibit recovery of the core 
carbohydrate synthesis (revealed by man nose uptakes at their depig-
menting concentrations), it seems reasonable to attribute the inter-
rupted recovery of melanization observed here to the inhibition of 
carbohydrate-processing pathways of cellular components essential 
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for melanogenesis. dNM [15] and CS [16] inhibit the formation of 
complex oligosaccharides by interfering with processing glucosi-
dases which function in the endoplasmic reticulum. MS [17- 19] 
blocks the trimming of high-mannose oligosaccharides and their 
conversion to complex oligosaccharides through movement from 
medial to the trans-Golgi cisternae. SW inhibits the processing 
cleavage of mannose after GlcNAc addition to high-mannose moie-
ties, resulting in the replacement of the complex glycoproteins by 
hybrid types (20,21 J (Fig 7). Thus, differential and sequential car-
bohydrate processing inhibition using dNM, CS, MS, and SW 
would provide information on carbohydrate structures essential for 
melanogenesis by tyrosinases. 
Multiple forms of tyrosinases, Th T 2, and T 3, have been shown to 
differ in respect to carbohydrate moieties, especially terminal sialic 
acid content, and to membrane-binding status of these isozymes 
(22). Available evidence [22] from enzyme digestion studies indi-
cates that T 1 is richer in terminal sialic acids than T 2 because T 2 
could be formed after neuraminidase treatment, while T 3 could be 
converted to T 1 after trypsin treatment. Recently Ohkura et al have 
determined [23] the structure of sugar chains on soluble T 1 tyrosin-
ase from malignant melanoma cells, and the results suggest that 
tyrosinases contain a spectrum of various steps of oligosaccharide 
processing toward complex types. In the presence of dNM, the 
pattern of soluble tyrosinase isozymcs (T, T J is considerably al-
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Figure 3. SDS-PAGE of tyrosinase present m LGF from processing 
inhibitor-treated cells on the second or third day of recovery. Tyrosinase 
activity is made visible with the dopa teacuon. A, MS. B, SW (40pg/ml) 
on day 3; Neu (+):neuraminidase treatment. C, dNM. D, Tp control on 
day 3: I, non-treatment; 2, 2-b incubation with buffer only; 3, 2-h 
incubation with neuram1mdase; Neu (+): neuramimdase rrearrnent; Con 
A, fractiOn after Con A affimty chromatography. E, dNM (1.6 mM) on 
day 2; Ncu (+): ncurammidase trcarment. 
tcred by the formation of a new soluble tyrosinase isozyme with a 
lower electrophoretic mobility than T 2, which is suggestive of non-
sialylated tyrostnase. Likewise, MS and SW induce poorly sialylated 
tyrosinase almost corresponding in mobility to T 2 tyrosinase. This 
implies that in our experimental system these agents function as 
processing inhibicors, giving rise to sialic acid-poor tyrosinases 
whose characteristics could never be seen in Tp-rreated control cells 
or in untreated melanoma cells [3]. These tyrosinases are completely 
different from those induced by the TM inhibition of the core 
carbohydrate synthesis. Because SW does not impair melanization 
in spite of its distinct effect on the carbohydrate moiety of tyrosin-
ases, it seems unlikely that sialic acid-rich tyrosinases (T1), which 
possesses highly processed types of carbohydrate, play a crucial role 
in the induction of melanization. 
Of considerable interest was the finding that the membrane-
bound form of tyrosinase T 3, which could be considered the fully 
processed enzyme, is definitely re-formed in the presence of MS, 
despite the selective loss during melanization recovery. In contrast, 
dNM inhibition seems to show no reformation of the T 3 tyrosinase. 
In accordance with the observed behavior of the tyrosinase iso-
zymes, electron microscopic observation demonstrates that a trans-
location of tyrosinases from GERL and coated vesicles to many 
vacuolar premelanosomes occurs in the MS-treated cells, in contrast 
to its predominant distribution in the GERL-coated vesicle system 
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Figure <4. A, Control Tp-rreated cultured B-16 melanotic melanoma cells on day 3 of recovery from glycosylarion anlub1tion. Note the numerous highly 
melamzed sphero1d mdano;omes (m). GTA-0,04; bar, 0.5 Jlm. 8, Elecrron m1croscop1c dopa reaction of conrrol Tp-rreated cells on day 2 of recovery. The 
cells exh1bit dopa-posmve melanosomes (m) as well as a strongly dopa-pos1nve reaction in a numberofGERL (gerl) and coated vesicles (cv). GTA-dopa (37"C, 
5h)-0,04; bar, 0.5 Jlm. 
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Figure 5. A, MS-rreared cells on day 3 of recovery exhibtt a complete absence of melamzation in premelano~omes (pm) wtth vestcles and filamentous 
marenals (arrow) . There arc numerous large vacuoles, most concaintng dtffusdy statnmg materi:~ls which are often condensed agamst the vacuolar membr:~ne. 
GTA-0,0
4
; bar, 0.5 J.lm. B. MS-rreatcd cells on day 2 of recovery exhibtc dopa-positive large vacuoles (arr(}U•), premelanosomes (pm). and coated vesicles (cv). 
GTA-dopa (37•c , 5 h)-0,04; bar, 0.5 J.lm. 
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Figure 6. A, dNM-trcatcd cell~ on day 3 of recovery exlub1t almost complete absence of melanizanon in the premelanosomes (pm) where a filamentous 
1mcrior with penod1ciry parually appears. GTA-0,0.: bar, 0.5 Jlm. 8, dNM-rreated cells on day 2 of recovery contain weakly dopa-positive or dopa-negative 
premelano;omc; (pm} although GERL (gerl} and coated vesicles (cv) exhibit strongly positive dopa reaction. GTA-dopa (37•c, 5 h)-0,0.: bar, 0.5 JLIU. 
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Figure 7. Pathway of glycoprotetn processmg and thctr mhtbltlon mcs. dNM, dcoxynoJtnmycmc; CS, castanospcrmm; MS. monensm; SW, swa~nsorune. 
of dNM-treated cells. A stmtlar dNM interruption of intracellular 
translocation of secretory proteins was observed forcathepsm D and 
P-hexosamimdase tn human fibroblast cells where accumulated 
precursors COtHam netther mannose-6-phosphate residues nor com-
plex type oltgosacchandes [24). 
The essential role of the formation of membrane-bound T 3 tyro-
smase in melanosomal melanization was suggested by our previous 
glycosylation mhibmon studies [3,25], which showed that loss and 
recovery of pigmentation correlate with the disappearance and 
reappearance of the membrane-bound tyrosinase T 3• The lack of 
mclanosomal melamzatton (despite the presence ofT3 tyrosinase} 
seen followmg MS treatment may be accounted for by the markedly 
aberrant internal structures of mclanosomes, which may result in an 
1mpa1rment of melanizing capacity of tyrosinascs. Therefore, the 
present findmgs suggest that the maturation and translocation of 
tyrosinase to premcl.1nosomes, whtch is necessary for the formation 
of membrane-bound T 3 tyrosinase, ts mamly associated with an 
early Hep of mannose-mmming of glycoproteins of tyrosmascs, but 
not wtth thetr pnor or subsequent carbohydrate processing path-
ways. 
There arc other examples which show that the removal of glu-
cose rcs1dues may be cnttcal for the transport and secretion of glyco-
protem. For example. the secretiOn of lgD [26) or 1-proteinase 
inhibitor 127,28] was blocked m the presence of dNM, wlule SW 
did not affect the release of either glycoprotein (29]. In this connec-
tion, it should be noted that in the lysosome system, coated vesicles 
play an essenrial role tn carrying lysosomal enzymes through the 
interaction between phosphomannosyl residues on the oligosaccha-
ride mo1et1es of lysosomal enzymes and mannose-6-phosphate re-
ceptors localized in lysosomes [30). Because the proposed step of the 
formation of mannose-6-phosphate on carbohydrate moieties of 
proteins precedes the processing pathway of glucose cleavage 
[31,32], which could be interrupted by dNM bur not by MS, our 
evtdence for differential tyrosinase transfer is in accordance with 
other studies showing the involvement of the mannose-6-phos-
phate receptor in intracellular translocation of secretory proteins 
[33,34]. On rhe other hand, the differential action on melanization 
between glycosylarion inhibitors for the early (dNM, CS, MS) and 
larer stages (SW} of the processing pathways suggests that the in 
vivo melanizing function of tyrosinases may be associated with the 
high-mannose type of carbohydrate. However, the possibility can-
not be entirely ruled out that undtscovered biolog1c factors other 
than carbohydrate processmg are involved in the observed loss of 
pigmentation following MS treatment because of known action of 
MS as sod tum ionophore (35]. 
In ptgment cells, premelanosomes are the only site where tyro-
sinase functions as a melarun synthestzmg enzyme desptte its various 
subcellular localtzations such as in the GERL and coated vesicles (2). 
Thus, it has been predicted that the premelanosome membrane 
con tams factors that activate tyrosinase or release 1ts naturally occur-
nng inhtbitors. The present processmg inhibition study suggests 
that although there is a diversity in the carbohydrate moieties of 
tyrosinases, their carbohydrate properties essential for melanogen-
esis may depend on particular steps m glucose and mannose trim-
ming stages through which carbohydrate moieties specific for intra-
cellular recognition are formed. Since melanizing ability of 
VOL 95. NO. I JULY 1990 
ryrosinases is expressed following their transfer to premelanosomes, 
it still remams unclarilied how tyrosinase activation within premel-
anosomcs which results in the induction of in vivo melanization ts 
involved in their carbohydrate moieties. 
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